Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FLT3 | P36888 | 9/20 | 0.51 |
| ▸ | IRAK4 | Q9NWZ3 | 6/20 | 0.47 |
| ▸ | USP30 | Q70CQ3 | 3/20 | 0.47 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.47 |
| ▸ | NRAS | P01111 | 3/20 | 0.46 |
| ▸ | SYK | P43405 | 1/20 | 0.43 |
| ▸ | IDH1 | O75874 | 1/20 | 0.43 |
| ▸ | LCK | P06239 | 1/20 | 0.42 |
| ▸ | RET | P07949 | 1/20 | 0.42 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.42 |
| ▸ | CDK7 | P50613 | 1/20 | 0.42 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.42 |
| ▸ | CCNH | P51946 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25764532 | 0.89 | FLT3 (0.53) | FLT3IRAK4USP30CCNT1NRAS | |
| SCHEMBL24574190 | 0.88 | FLT3 (0.51) | FLT3IRAK4USP30CCNT1NRAS | |
| SCHEMBL24574511 | 0.87 | FLT3 (0.53) | FLT3IRAK4USP30CCNT1NRAS | |
| SCHEMBL24574159 | 0.87 | FLT3 (0.51) | FLT3IRAK4USP30CCNT1NRAS | |
| SCHEMBL24574154 | 0.87 | FLT3 (0.51) | FLT3IRAK4USP30CCNT1NRAS | |
| SCHEMBL19899931 | 0.87 | FLT3 (0.52) | FLT3IRAK4USP30CCNT1NRAS | |
| SCHEMBL24231714 | 0.87 | FLT3 (0.52) | FLT3IRAK4USP30CCNT1NRAS | |
| SCHEMBL24231649 | 0.87 | FLT3 (0.48) | FLT3IRAK4USP30CCNT1NRAS | |
| SCHEMBL24231604 | 0.87 | FLT3 (0.58) | FLT3IRAK4USP30CCNT1NRAS | |
| SCHEMBL24231869 | 0.87 | FLT3 (0.58) | FLT3IRAK4USP30CCNT1NRAS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3854796-A1 | IMIDAZO[1,2-A]PYRIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM, METHODS FOR TREATING DISEASES USING THEM, AND METHODS FOR PREPARING THEM | Children's Hospital Medical Center (US) | 2021-07-28 | — | — | EP | disclosed |
| WO-2018038988-A2 | COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2018-03-01 | — | — | WO | disclosed |